X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/09/07/2739080/0/en/Fennec-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2023/08/03/2717728/0/en/Fennec-Pharmaceuticals-Announces-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2023/07/31/2714638/0/en/Fennec-Pharmaceuticals-to-Report-Second-Quarter-2023-Financial-Results-on-August-3-2023.html
https://www.globenewswire.com/news-release/2023/06/12/2686714/0/en/Fennec-Announces-Results-of-Annual-Meeting.html
https://www.biospace.com/article/fennec-pharmaceuticals-announces-european-commission-marketing-authorization-for-pedmarqsi-sodium-thiosulfate-to-reduce-the-risk-of-hearing-loss-in-pediatric-oncology-patients/
https://www.globenewswire.com/news-release/2023/06/06/2682568/0/en/Fennec-Pharmaceuticals-Announces-European-Commission-Marketing-Authorization-for-Pedmarqsi-sodium-thiosulfate-to-Reduce-the-Risk-of-Hearing-Loss-in-Pediatric-Oncology-Patients.html
https://www.ema.europa.eu/en/documents/overview/pedmarqsi-epar-medicine-overview_en.pdf
https://www.globenewswire.com/news-release/2023/05/11/2666436/0/en/Fennec-Pharmaceuticals-Announces-First-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2023/05/08/2663099/0/en/Fennec-Pharmaceuticals-to-Report-First-Quarter-2023-Financial-Results-on-May-11-2023.html
https://www.globenewswire.com/news-release/2023/03/31/2638604/0/en/Fennec-Pharmaceuticals-Receives-Positive-CHMP-Opinion-for-Pedmarqsi-sodium-thiosulfate-to-Reduce-the-Risk-of-Hearing-Loss-in-Pediatric-Oncology-Patients.html
Market Place
Share 
